121 related articles for article (PubMed ID: 18942777)
1. Using short-term evidence to predict six-month outcomes in clinical trials of signs and symptoms in rheumatoid arthritis.
Nixon RM; Bansback N; Stevens JW; Brennan A; Madan J
Pharm Stat; 2009; 8(2):150-62. PubMed ID: 18942777
[TBL] [Abstract][Full Text] [Related]
2. The Rheumatoid Arthritis Drug Development Model: a case study in Bayesian clinical trial simulation.
Nixon RM; O'Hagan A; Oakley J; Madan J; Stevens JW; Bansback N; Brennan A
Pharm Stat; 2009; 8(4):371-89. PubMed ID: 19340851
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.
Ogrendik M
Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134
[TBL] [Abstract][Full Text] [Related]
4. What drives the comparative effectiveness of biologics vs. methotrexate in rheumatoid arthritis? Meta-regression and graphical inspection of suspected clinical factors.
Kanters S; Druyts E; Mills EJ; Thorlund K
Rheumatology (Oxford); 2014 Jul; 53(7):1264-73. PubMed ID: 24599922
[TBL] [Abstract][Full Text] [Related]
5. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations.
Aletaha D; Landewe R; Karonitsch T; Bathon J; Boers M; Bombardier C; Bombardieri S; Choi H; Combe B; Dougados M; Emery P; Gomez-Reino J; Keystone E; Koch G; Kvien TK; Martin-Mola E; Matucci-Cerinic M; Michaud K; O'Dell J; Paulus H; Pincus T; Richards P; Simon L; Siegel J; Smolen JS; Sokka T; Strand V; Tugwell P; van der Heijde D; van Riel P; Vlad S; van Vollenhoven R; Ward M; Weinblatt M; Wells G; White B; Wolfe F; Zhang B; Zink A; Felson D
Ann Rheum Dis; 2008 Oct; 67(10):1360-4. PubMed ID: 18791055
[TBL] [Abstract][Full Text] [Related]
6. Bayesian optimal designs for a quantal dose-response study with potentially missing observations.
Baek I; Zhu W; Wu X; Wong WK
J Biopharm Stat; 2006; 16(5):679-93. PubMed ID: 17037265
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of rheumatoid arthritis.
Sokka T
Curr Opin Rheumatol; 2009 May; 21(3):284-90. PubMed ID: 19342954
[TBL] [Abstract][Full Text] [Related]
8. Using mixed treatment comparisons and meta-regression to perform indirect comparisons to estimate the efficacy of biologic treatments in rheumatoid arthritis.
Nixon RM; Bansback N; Brennan A
Stat Med; 2007 Mar; 26(6):1237-54. PubMed ID: 16900557
[TBL] [Abstract][Full Text] [Related]
9. What is the best source of useful data on the treatment of rheumatoid arthritis: clinical trials, clinical observations, or clinical protocols?
Pincus T; Stein CM
J Rheumatol; 1995 Sep; 22(9):1611-7. PubMed ID: 8523331
[No Abstract] [Full Text] [Related]
10. Assessment and management of rheumatoid arthritis.
Haraoui B
J Rheumatol Suppl; 2009 Jun; 82():2-10. PubMed ID: 19509324
[TBL] [Abstract][Full Text] [Related]
11. Predicting analysis times in randomized clinical trials.
Bagiella E; Heitjan DF
Stat Med; 2001 Jul; 20(14):2055-63. PubMed ID: 11439420
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis.
Cohen SB; Cheng TT; Chindalore V; Damjanov N; Burgos-Vargas R; Delora P; Zimany K; Travers H; Caulfield JP
Arthritis Rheum; 2009 Feb; 60(2):335-44. PubMed ID: 19180516
[TBL] [Abstract][Full Text] [Related]
13. Sample-size calculations for studies with correlated ordinal outcomes.
Kim HY; Williamson JM; Lyles CM
Stat Med; 2005 Oct; 24(19):2977-87. PubMed ID: 16149125
[TBL] [Abstract][Full Text] [Related]
14. Unresolved issues in identifying and overcoming inadequate response in rheumatoid arthritis: weighing the evidence.
Cohen SB; Cohen MD; Cush JJ; Fleischmann RM; Mease PJ; Schiff MH; Simon LS; Weaver AL
J Rheumatol Suppl; 2008 Feb; 81():4-30; quiz 31-4. PubMed ID: 19193621
[TBL] [Abstract][Full Text] [Related]
15. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.
Wijeysundera DN; Austin PC; Hux JE; Beattie WS; Laupacis A
J Clin Epidemiol; 2009 Jan; 62(1):13-21.e5. PubMed ID: 18947971
[TBL] [Abstract][Full Text] [Related]
16. Nonparametric empirical Bayes method for comparison of treatment effects with application to stress urinary incontinence data.
Liu C; Shen W; Xie J
Pharm Stat; 2008; 7(1):42-52. PubMed ID: 17311241
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate in combination with sulfasalazine is more effective in rheumatoid arthritis patients who failed sulfasalazine than in patients naive to both drugs.
Schipper LG; Fransen J; Barrera P; Van Riel PL
Rheumatology (Oxford); 2009 Jul; 48(7):828-33. PubMed ID: 19458163
[TBL] [Abstract][Full Text] [Related]
18. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
[TBL] [Abstract][Full Text] [Related]
19. The BeSt story: on strategy trials in rheumatoid arthritis.
Klarenbeek NB; Allaart CF; Kerstens PJ; Huizinga TW; Dijkmans BA
Curr Opin Rheumatol; 2009 May; 21(3):291-8. PubMed ID: 19318946
[TBL] [Abstract][Full Text] [Related]
20. Issues in the design of new clinical trials for rheumatoid arthritis therapeutics.
Schwieterman WD
Nat Clin Pract Rheumatol; 2008 Dec; 4(12):641-8. PubMed ID: 19037225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
